Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL396935 | 0.83 | THRB (0.42) | TSHRALDH1A1THRB | |
| SCHEMBL35615 | 0.81 | TSHR (0.46) | TSHRALDH1A1THRB | |
| SCHEMBL396764 | 0.80 | TSHR (0.47) | TSHRALDH1A1THRB | |
| SCHEMBL29011426 | 0.80 | TSHR (0.45) | TSHRALDH1A1THRB | |
| SCHEMBL580729 | 0.77 | THRB (0.50) | TSHRALDH1A1THRB | |
| SCHEMBL3915024 | 0.77 | TSHR (0.48) | TSHRALDH1A1THRB | |
| SCHEMBL396294 | 0.77 | TSHR (0.41) | TSHRALDH1A1THRB | |
| SCHEMBL397012 | 0.76 | TSHR (0.43) | TSHRALDH1A1THRB | |
| SCHEMBL537010 | 0.75 | TSHR (0.46) | TSHRALDH1A1THRB | |
| SCHEMBL4883024 | 0.74 | TSHR (0.42) | TSHRALDH1A1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 226 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600820-B2 | Photocurable composition with high silicon content | CANON KABUSHIKI KAISHA (JP) | 2026-04-14 | — | — | US | claimed |
| US-20250368802-A1 | PHOTOCURABLE COMPOSITION WITH HIGH SILICON CONTENT AND HIGH STABILITY | CANON KK (JP) | 2025-12-04 | — | — | US | claimed |
| US-12358933-B2 | Meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | PIOCEL CO., LTD. (KR) | 2025-07-15 | — | — | US | claimed |
| US-20250109153-A1 | A novel meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | PIOCEL CO., LTD. (KR) | 2025-04-03 | — | — | US | claimed |
| US-20240199816-A1 | PHOTOCURABLE COMPOSITION WITH HIGH SILICON CONTENT | CANON KABUSHIKI KAISHA (JP) | 2024-06-20 | — | — | US | claimed |
| WO-2024123531-A1 | PHOTOCURABLE COMPOSITION WITH HIGH SILICON CONTENT | CANON KABUSHIKI KAISHA (JP) | 2024-06-13 | — | — | WO | claimed |
| WO-2023153586-A1 | NOVEL META-POLYHEDRAL OLIGOMERIC SILSESQUIOXANE (META-POSS) COMPOUND, PRODUCTION METHOD THEREFOR, AND COMPOSITION COMPRISING META-POSS COMPOUND PRODUCED THEREBY | 주식회사 파이오셀 | 2023-08-17 | — | — | WO | claimed |
| CN-110235262-B | Composition for organic electronic device sealant and sealant formed using the same | 莫门蒂夫性能材料韩国株式会社 | 2023-07-18 | — | — | CN | claimed |
| EP-1945231-B1 | CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | ROCHAL PARTNERS LLP (US) | 2021-11-10 | — | — | EP | claimed |
| US-10553824-B2 | Encapsulation composition for organic electronic device, and encapsulation formed using same | MOMENTIVE PERFORMANCE MATERIALS KOREA CO., LTD. (KR) | 2020-02-04 | — | — | US | claimed |
| WO-2013052276-A1 | SACRIFICIAL ADHESIVE COATINGS | ROCHAL INDUSTRIES, LLP (US) | 2013-04-11 | — | — | WO | claimed |
| US-8263720-B1 | Sacrificial adhesive coatings | ROCHAL INDUSTRIES, LLP (US) | 2012-09-11 | — | — | US | claimed |
| WO-2012109228-A1 | LOW-TACK, HYDROPHOBIC OPHTHALMIC DEVICE MATERIALS | NOVARTIS AG (CH) | 2012-08-16 | — | — | WO | claimed |
| US-20120202916-A1 | Low-Tack, Hydrophobic Ophthalmic Device Materials | NOVARTIS AG (CH) | 2012-08-09 | — | — | US | claimed |
| US-8197803-B2 | Method of forming a conformable solvent-based bandage and coating material | ROCHAL INDUSTRIES, LLP (US) | 2012-06-12 | — | — | US | claimed |
| US-20120114729-A1 | SILICONE-PEROXIDE COMPOSITIONS FOR LONG-TERM, CONTROLLED OXYGEN RELEASE | UNIVERSITY OF MIAMI (US) | 2012-05-10 | — | — | US | claimed |
| US-8142970-B2 | Toner compositions | XEROX CORPORATION (US) | 2012-03-27 | — | — | US | claimed |
| WO-2010121024-A2 | SILICONE-PEROXIDE COMPOSITIONS FOR LONG-TERM, CONTROLLED OXYGEN RELEASE | UNIVERSITY OF MIAMI (US) | 2010-10-21 | — | — | WO | claimed |
| US-20090210002-A1 | METHOD OF FORMING A CONFORMABLE SOLVENT-BASED BANDAGE AND COATING MATERIAL | ROCHAL INDUSTRIES LLP (US) | 2009-08-20 | — | — | US | claimed |
| US-20070041935-A1 | Polymerizable cyanoacrylate monomer and volatile liquid selected from linear and cyclic siloxanes, polydimethylsiloxanes, isooctane, and octane; kits | ROCHAL PARTNERS LLP | 2007-02-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12358933-B2 | Meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | SPEN, SAE1, OSTC | TSHR 3556/4885ALDH1A1 4639/4885THRB 3131/4885 |
| US-12600820-B2 | Photocurable composition with high silicon content | BIRC2, ACP1, IRS1 | TSHR 4173/4885ALDH1A1 3351/4885THRB 4666/4885 |
| US-20250109153-A1 | A novel meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | SPEN, SAE1, SOST | TSHR 3789/4885ALDH1A1 4652/4885THRB 3126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.